Cargando…
Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review
Introduction. Uterine leiomyomas, also called uterine fibroids or myomas, are the most common pelvic tumors in women. They are very rarely the cause of acute complications. However, when complications occur they cause significant morbidity and mortality. Thromboembolic disease has been described as...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112332/ https://www.ncbi.nlm.nih.gov/pubmed/27885348 http://dx.doi.org/10.1155/2016/9803250 |
_version_ | 1782467976089305088 |
---|---|
author | Satti, Mohamed A. Paredes Saenz, Carmen Raju, Rubin Cuthpert, Sierra Kanzy, Abed Abhari, Sina Hebert III, John Rocha, Frederico G. |
author_facet | Satti, Mohamed A. Paredes Saenz, Carmen Raju, Rubin Cuthpert, Sierra Kanzy, Abed Abhari, Sina Hebert III, John Rocha, Frederico G. |
author_sort | Satti, Mohamed A. |
collection | PubMed |
description | Introduction. Uterine leiomyomas, also called uterine fibroids or myomas, are the most common pelvic tumors in women. They are very rarely the cause of acute complications. However, when complications occur they cause significant morbidity and mortality. Thromboembolic disease has been described as a rare complication of uterine leiomyomas. DVT is a serious illness, sometimes causing death due to acute PE. Cases. We report a case series of 3 patients with thromboembolic disease associated with uterine leiomyoma at Hurley Medical Center, Flint, Michigan, during 2015 and conduct a literature review on the topic. A literature search was conducted using Medline, PubMed, and PMC databases from 1966 to 2015. Conclusion. The uterine leiomyoma is a very rare cause of PE and only few cases have been reported. DVT secondary to uterine leiomyoma should be considered in a female presenting with abdominal mass and pelvic pressure, if there is no clear common cause for her symptoms. Thromboembolic disease secondary to large uterine leiomyoma should be treated with acute stabilization and then hysterectomy. Prophylactic anticoagulation would be beneficial for lowering the risk of VTE in patients with large uterine leiomyoma. |
format | Online Article Text |
id | pubmed-5112332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-51123322016-11-24 Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review Satti, Mohamed A. Paredes Saenz, Carmen Raju, Rubin Cuthpert, Sierra Kanzy, Abed Abhari, Sina Hebert III, John Rocha, Frederico G. Case Rep Obstet Gynecol Case Report Introduction. Uterine leiomyomas, also called uterine fibroids or myomas, are the most common pelvic tumors in women. They are very rarely the cause of acute complications. However, when complications occur they cause significant morbidity and mortality. Thromboembolic disease has been described as a rare complication of uterine leiomyomas. DVT is a serious illness, sometimes causing death due to acute PE. Cases. We report a case series of 3 patients with thromboembolic disease associated with uterine leiomyoma at Hurley Medical Center, Flint, Michigan, during 2015 and conduct a literature review on the topic. A literature search was conducted using Medline, PubMed, and PMC databases from 1966 to 2015. Conclusion. The uterine leiomyoma is a very rare cause of PE and only few cases have been reported. DVT secondary to uterine leiomyoma should be considered in a female presenting with abdominal mass and pelvic pressure, if there is no clear common cause for her symptoms. Thromboembolic disease secondary to large uterine leiomyoma should be treated with acute stabilization and then hysterectomy. Prophylactic anticoagulation would be beneficial for lowering the risk of VTE in patients with large uterine leiomyoma. Hindawi Publishing Corporation 2016 2016-11-03 /pmc/articles/PMC5112332/ /pubmed/27885348 http://dx.doi.org/10.1155/2016/9803250 Text en Copyright © 2016 Mohamed A. Satti et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Satti, Mohamed A. Paredes Saenz, Carmen Raju, Rubin Cuthpert, Sierra Kanzy, Abed Abhari, Sina Hebert III, John Rocha, Frederico G. Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title | Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title_full | Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title_fullStr | Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title_full_unstemmed | Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title_short | Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review |
title_sort | should prophylactic anticoagulation be considered with large uterine leiomyoma? a case series and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112332/ https://www.ncbi.nlm.nih.gov/pubmed/27885348 http://dx.doi.org/10.1155/2016/9803250 |
work_keys_str_mv | AT sattimohameda shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT paredessaenzcarmen shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT rajurubin shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT cuthpertsierra shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT kanzyabed shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT abharisina shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT hebertiiijohn shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview AT rochafredericog shouldprophylacticanticoagulationbeconsideredwithlargeuterineleiomyomaacaseseriesandliteraturereview |